Rare lephants
Screener

Charles River Laboratories International, Inc.

CRL ·Healthcare, Diagnostics & Research, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Aug 6, 2026 PRIMARY DOCUMENT
144 Aug 6, 2026
144 Aug 6, 2026
SCHEDULE 13G/A Aug 6, 2026
144 Aug 5, 2026
10-Q Aug 5, 2026 10-Q
8-K Aug 5, 2026 8-K
4 Jul 1, 2026 PRIMARY DOCUMENT
144 Jun 29, 2026
4 Jun 8, 2026 PRIMARY DOCUMENT
4 Jun 8, 2026 PRIMARY DOCUMENT
4 Jun 8, 2026 PRIMARY DOCUMENT
4 Jun 3, 2026 PRIMARY DOCUMENT
4 Jun 2, 2026 PRIMARY DOCUMENT
4 Jun 2, 2026 PRIMARY DOCUMENT
4 Jun 2, 2026 PRIMARY DOCUMENT
4 Jun 2, 2026 PRIMARY DOCUMENT
4 Jun 2, 2026 PRIMARY DOCUMENT
4 Jun 2, 2026 PRIMARY DOCUMENT
4 Jun 2, 2026 PRIMARY DOCUMENT
4 Jun 2, 2026 PRIMARY DOCUMENT
4 May 28, 2026 PRIMARY DOCUMENT
4 May 28, 2026 PRIMARY DOCUMENT
4 May 28, 2026 PRIMARY DOCUMENT
4 May 28, 2026 PRIMARY DOCUMENT
← Newer Page 2 of 98 · 2432 filings Older →